Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$5.77 - $8.49 $21,926 - $32,262
3,800 Added 31.67%
15,800 $408,000
Q3 2022

Nov 14, 2022

SELL
$3.75 - $7.39 $3,000 - $5,912
-800 Reduced 6.25%
12,000 $397,000
Q2 2022

Aug 12, 2022

SELL
$2.94 - $5.23 $2,646 - $4,707
-900 Reduced 6.57%
12,800 $428,000
Q1 2022

May 12, 2022

SELL
$4.07 - $10.6 $23,199 - $60,420
-5,700 Reduced 29.38%
13,700 $412,000
Q4 2021

Feb 14, 2022

SELL
$8.96 - $16.31 $36,736 - $66,871
-4,100 Reduced 17.45%
19,400 $485,000
Q3 2021

Nov 10, 2021

BUY
$11.24 - $21.0 $31,472 - $58,800
2,800 Added 13.53%
23,500 $527,000
Q2 2021

Aug 11, 2021

SELL
$18.04 - $22.09 $19,844 - $24,299
-1,100 Reduced 5.05%
20,700 $356,000
Q1 2021

May 14, 2021

BUY
$16.59 - $33.89 $16,590 - $33,890
1,000 Added 4.81%
21,800 $360,000
Q4 2020

Feb 16, 2021

SELL
$27.5 - $37.92 $167,750 - $231,312
-6,100 Reduced 22.68%
20,800 $421,000
Q3 2020

Nov 13, 2020

SELL
$34.44 - $43.75 $1.22 Million - $1.55 Million
-35,400 Reduced 56.82%
26,900 $251,000
Q2 2020

Aug 10, 2020

BUY
$27.12 - $45.97 $1.29 Million - $2.18 Million
47,500 Added 320.95%
62,300 $344,000
Q1 2020

May 08, 2020

SELL
$26.16 - $63.5 $852,816 - $2.07 Million
-32,600 Reduced 68.78%
14,800 $493,000
Q4 2019

Feb 11, 2020

BUY
$46.96 - $61.67 $1.73 Million - $2.27 Million
36,800 Added 347.17%
47,400 $503,000
Q3 2019

Nov 12, 2019

SELL
$59.47 - $93.1 $77,311 - $121,029
-1,300 Reduced 10.92%
10,600 $247,000
Q2 2019

Aug 14, 2019

SELL
$75.84 - $105.21 $68,256 - $94,689
-900 Reduced 7.03%
11,900 $147,000
Q1 2019

May 10, 2019

SELL
$64.44 - $104.11 $128,880 - $208,220
-2,000 Reduced 13.51%
12,800 $74,000
Q4 2018

Feb 12, 2019

BUY
$59.1 - $93.26 $53,190 - $83,934
900 Added 6.47%
14,800 $198,000
Q1 2018

May 11, 2018

SELL
$105.8 - $150.94 $518,420 - $739,606
-4,900 Reduced 26.06%
13,900 $232,000
Q4 2017

Feb 09, 2018

BUY
$81.25 - $130.7 $1.53 Million - $2.46 Million
18,800
18,800 $81,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.